Skip to content

Longitudinal Changes in Ocular Surface Microbiome with Prolonged Topical Steroid Use: A Cohort Study in Endothelial Keratoplasty Patients

Longitudinal Changes in Ocular Surface Microbiome with Prolonged Topical Steroid Use: A Cohort Study in Endothelial Keratoplasty Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20241116005
Enrollment
38
Registered
2024-11-16
Start date
2025-02-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endothelial keratoplasty ocular surface microbiome, endothelial keratoplasty, long-term topical steroids

Interventions

Participants who have endothelial keratoplasty surgery observed from baseline (preoperation) and after 12 months of topical steroids post-surgery,Healthy controls - one-time sampling collection for co
Basic Science,Basic Science
Endothelial keratoplasty (EK) - 28 participants,Healthy control - 10 participants

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Participants will be eligible for inclusion if they meet the following criteria: 1. Patients with indications for endothelial keratoplasty (EK) surgery, including EK with or without phacoemulsification. 2. Residents of Thailand. 3. Individuals aged 18 years and older who provide informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: The exclusion criteria will be applied during the screening and enrollment phase to ensure appropriate participant selection: 1. Poorly controlled diabetes mellitus 2. History of graft failure following a previous keratoplasty. 3. History of herpes simplex virus (HSV) keratitis or chronic ocular surface diseases (e.g., blepharitis, conjunctivitis, severe meibomian gland dysfunction, severe dry eye disease ). 4. History of any ocular surgery within the last three months 5. Use of contact lenses, topical antibiotics, or antiglaucoma eye drops within one month prior to sample collection.

Design outcomes

Primary

MeasureTime frame
Microbiome at baseline (preoperation), 3 months and 12 months after surgery alpha-diversity, beta-diversity, bacterial relative abundance

Secondary

MeasureTime frame
Positive strains, microbial susceptibility results baseline (preoperation), 3 months, 12 months after surgery Conventional culture

Countries

Thailand

Contacts

Public ContactVilavun Puangsricharern

King Chulalongkorn Memorial Hospital

vilavun@hotmail.com0830122999

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026